Christopher W. Fulton

Array ( [id] => 7074331 [patent_doc_number] => 20050147599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/006889 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 394041 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147599.pdf [firstpage_image] =>[orig_patent_app_number] => 11006889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813833 [patent_doc_number] => 07414107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis' [patent_app_type] => utility [patent_app_number] => 11/007772 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32246 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414107.pdf [firstpage_image] =>[orig_patent_app_number] => 11007772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913552 [patent_doc_number] => 20060128614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Antimicrobial peptides with reduced hemolysis and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/000970 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128614.pdf [firstpage_image] =>[orig_patent_app_number] => 11000970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105777 [patent_doc_number] => 20050107584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome' [patent_app_type] => utility [patent_app_number] => 10/997989 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11712 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107584.pdf [firstpage_image] =>[orig_patent_app_number] => 10997989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345122 [patent_doc_number] => 07498309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Pharmaceutical compositions for bioactive peptide agents' [patent_app_type] => utility [patent_app_number] => 11/000328 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498309.pdf [firstpage_image] =>[orig_patent_app_number] => 11000328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960520 [patent_doc_number] => 20080274945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Infant Nutrition With Protease Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/720307 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6517 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274945.pdf [firstpage_image] =>[orig_patent_app_number] => 11720307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110685 [patent_doc_number] => 20050208140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Short peptide carrier system for cellular delivery of agent' [patent_app_type] => utility [patent_app_number] => 10/997036 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8837 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208140.pdf [firstpage_image] =>[orig_patent_app_number] => 10997036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4549941 [patent_doc_number] => 07960504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Inhibitors of HIV membrane fusion' [patent_app_type] => utility [patent_app_number] => 10/987687 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 50 [patent_no_of_words] => 26113 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960504.pdf [firstpage_image] =>[orig_patent_app_number] => 10987687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 922964 [patent_doc_number] => 07318936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Minimization of drug oxidation in drug irradiated excipients formulations' [patent_app_type] => utility [patent_app_number] => 10/986922 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3045 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/318/07318936.pdf [firstpage_image] =>[orig_patent_app_number] => 10986922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866007 [patent_doc_number] => 20060100138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Implantable collagen compositions' [patent_app_type] => utility [patent_app_number] => 10/985570 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12575 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100138.pdf [firstpage_image] =>[orig_patent_app_number] => 10985570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103057 [patent_doc_number] => 07723469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Stabilized alpha helical peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/981873 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 83 [patent_no_of_words] => 19101 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723469.pdf [firstpage_image] =>[orig_patent_app_number] => 10981873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939745 [patent_doc_number] => 20050113308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Pentapeptide compounds and uses related thereto' [patent_app_type] => utility [patent_app_number] => 10/979923 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22799 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113308.pdf [firstpage_image] =>[orig_patent_app_number] => 10979923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748621 [patent_doc_number] => 20060111553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Novel thrombin inhibitors, the preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 10/973643 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43258 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111553.pdf [firstpage_image] =>[orig_patent_app_number] => 10973643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569195 [patent_doc_number] => 07462599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Use of effectors of glutaminyl and glutamate cyclases' [patent_app_type] => utility [patent_app_number] => 10/966645 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27229 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462599.pdf [firstpage_image] =>[orig_patent_app_number] => 10966645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408328 [patent_doc_number] => 07285646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Ultrapure transferrin for pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/964394 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 4 [patent_no_of_words] => 8006 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285646.pdf [firstpage_image] =>[orig_patent_app_number] => 10964394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046518 [patent_doc_number] => 20070265192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications' [patent_app_type] => utility [patent_app_number] => 10/574475 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5927 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265192.pdf [firstpage_image] =>[orig_patent_app_number] => 10574475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010672 [patent_doc_number] => 20050064388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods and compositions for treating atheroma, tumors and other neoplastic tissue' [patent_app_type] => utility [patent_app_number] => 10/950302 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15969 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064388.pdf [firstpage_image] =>[orig_patent_app_number] => 10950302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930773 [patent_doc_number] => 20050281807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Use of C-reactive protein to treat immune complex-mediated renal disease' [patent_app_type] => utility [patent_app_number] => 10/947267 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4306 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281807.pdf [firstpage_image] =>[orig_patent_app_number] => 10947267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544855 [patent_doc_number] => 07166695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Affinity markers for human serum albumin' [patent_app_type] => utility [patent_app_number] => 10/934841 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 19222 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166695.pdf [firstpage_image] =>[orig_patent_app_number] => 10934841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624458 [patent_doc_number] => 08003756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Agent derived from tortoise spleen stimulating mammalian hemopoiesis' [patent_app_type] => utility [patent_app_number] => 10/570456 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 10096 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003756.pdf [firstpage_image] =>[orig_patent_app_number] => 10570456 [rel_patent_id] =>[rel_patent_doc_number] =>)